OREGON: More than fifty of Oregon’s registered medical marijuana patients are under the age of 14. These children typically use one or more components, called cannabinoids, extracted from cannabis, to control cancer (and arguably send it into remission,) or to address OCD and pediatric epilepsy or to abate symptoms like chronic pain.
These results are achieved, patients and their parents say, without the dangerous side effects of conventional pharmaceuticals.
Medical studies around the world suggest that these uses are valid and beneficial and the American Medical Association has proposed reclassifying research into medical marijuana so it has a higher priority; one study at the University of California San Francisco began this spring.
However, the young Oregonians and their families say that, in addition to fighting a daily battle against combative medical conditions, they also face prejudice and derision and frequently feel pressure to keep quiet about their therapy.